Integra LifeSciences Holdings Corporation

Good day and welcome to the Integrate Life Sciences third quarter 2021 financial results call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mike Bollier, Director of Investor Relations. Please go ahead, sir.

Thank you, Cecilia. Good morning, and thank you for joining the Integrate Life Sciences third quarter 2021 earnings conference call. Joining me on the call are Peter Arduini, President and Chief Executive Officer of Glenn Coleman, Chief Operating Officer, and Carrie Anderson, Chief Financial Officer. Earlier today, we issued a press release announcing our third quarter 2021 financial results. Along with the release, a corresponding earnings presentation, which we will reference during the call, is available at IntegralLife.com under Investors, Events and Presentations, with the file named Third Quarter 2021 Earnings Call Presentation. Before we begin, I'd like to remind you that the statements made during this call may be considered forward-looking. Factors that could cause actual results to differ materially are discussed in the company's Exchange Act reports, filed with the SEC, and in the release. Also, in our prepared remarks, we will make reference to both reported and organic revenue growth. Organic revenue growth excludes the effects of foreign currency, acquisitions including ASEL, divestitures including the sale of our extremity orthopedics business, as well as discontinued products. Unless otherwise stated, all disaggregated and franchise-level revenue growth rates are based on organic performance. Lastly, our comments today will include certain non-GAAP financial measures. Reconciliations of any non-GAAP financial measures can be found in today's press release, which is an exhibit to Integra's current report on Form 8-K, filed today with the SEC.

With that, I'll turn the call over to Pete. Thank you, Mike, and good morning, everyone. If you'll please turn to slide five, I'd like to make a few brief remarks regarding the CEO transition. Last Thursday, we issued a press release announcing that after a comprehensive search of candidates, our board has appointed Jan DeWitt as its next president and chief executive officer. Jan brings significant leadership experience and capabilities, including digital innovation and new product development, commercial acceleration, and international market expertise, and operational excellence. as well as a global mindset. As I noted on the second quarter earnings call, Integra has an outstanding leadership team capable of executing our strategic plan with a robust pipeline of innovative new products to drive global growth and market expansion for years to come. I have every confidence that Jan will build on Integra's strong foundation to drive the next phase of our profitable growth strategy, and I'll work closely with him over the coming months to ensure a seamless transition. Jan will be joining us prior to the end of the year as we work through the logistics of moving him and his family to the United States from Belgium. I'd also like to extend my sincere thanks to Stuart Essek and the Board of Directors, Integra's exceptional management team, and the more than 3,700 employees around the world. It's been an amazing 11 years at Integra, and I remain a huge supporter and look forward to Jan's many contributions as Integra's next CEO. Now, I'd like to turn the call over to Glenn to discuss our accomplishments and performance in the third quarter. Glenn?